Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more here.

Inovio Pharmaceuticals Inc. closed $12.82 below its 52-week high ($14.75), which the company achieved on April 1st.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.

The upside in Precigen's stock comes after it completes the rolling submission of an FDA filing for its first potentially marketed product.

State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

26.79% of the stock is owned by institutional investors. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever INO has been the ...